These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Decrease in urinary excretion of 3-methylhistidine by patients with Duchenne muscular dystrophy during glucocorticoid treatment. Kawai H; Adachi K; Nishida Y; Inui T; Kimura C; Saito S J Neurol; 1993; 240(3):181-6. PubMed ID: 8482992 [TBL] [Abstract][Full Text] [Related]
66. Serial manual muscle testing in Duchenne muscular dystrophy. Kilmer DD; Abresch RT; Fowler WM Arch Phys Med Rehabil; 1993 Nov; 74(11):1168-71. PubMed ID: 8239956 [TBL] [Abstract][Full Text] [Related]
67. Alterations in creatine kinase in fresh muscle and cell cultures in Duchenne dystrophy. Ionasescu V; Ionasescu R; Feld R; Witte D; Cancilla P; Kaeding L; Stern LZ Ann Neurol; 1981 Apr; 9(4):394-9. PubMed ID: 7224603 [TBL] [Abstract][Full Text] [Related]
68. Creatine kinase activity in normal and Duchenne muscular dystrophy fibroblasts. Davis MH; Cappel R; Vester JW; Samaha FJ; Gruenstein E Muscle Nerve; 1982 Jan; 5(1):1-6. PubMed ID: 7057800 [TBL] [Abstract][Full Text] [Related]
69. Studies on the creatine kinase MM isoforms of normal and Duchenne muscular dystrophic patients. Zhao X; Bi C; Yang Z Chin Med J (Engl); 1998 Jan; 111(1):75-7. PubMed ID: 10322660 [TBL] [Abstract][Full Text] [Related]
70. Effect of dantrolene in Duchenne muscular dystrophy. Bertorini TE; Palmieri GM; Griffin J; Igarashi M; Hinton A; Karas JG Muscle Nerve; 1991 Jun; 14(6):503-7. PubMed ID: 1852156 [TBL] [Abstract][Full Text] [Related]